Second Genome and Mayo Clinic Enter Collaboration to Develop Microbiome Therapeutics in Multiple Diseases
October 7, 2014, South San Francisco, CA
Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Scientific Officer
September 2, 2014, South San Francisco, CA
Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in Obesity
May 2, 2014, South San Francisco, CA
Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis
June 5, 2013, San Bruno, CA
Second Genome Sponsors American Gut Initiative to Identify Links Between Type 2 Diabetes and the Human Microbiome
January 3, 2013, San Francisco, CA
Second Genome Presents Preclinical Research on the Impact of the Microbiome on C. difficile Infection
November 2, 2012, San Bruno, CA
Second Genome Announces Human Microbiome Project Publications
June 13, 2012, San Bruno, CA
Second Genome Announces Expansion of Scientific Advisory Board
March 31, 2012, San Bruno, CA
